Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #102
- Final score
- 65.62
- Years on list
- 6
↘ Down 91 since 2020
Compare · Up to four Russell 1000 companies
Select two, three, or four Russell 1000 companies to compare their overall rank, year-by-year trajectory, and scores down to the category level.
Figure 01 · Side-by-side summary
Pharmaceuticals, Biotechnology & Life Sciences
↘ Down 91 since 2020
Pharmaceuticals, Biotechnology & Life Sciences
↘ Down 52 since 2020
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 162 since 2020
Figure 02 · Rank trajectory
Lower is better. The y-axis is inverted so a rising line means an improving rank. Missing years mean the company didn't make the top 100 that year.
Figure 03 · Pillar profile · 2025
Latest-year ESG pillar scores, 0–100. The shaded bar shows relative strength across the selected companies for each pillar.
| Pillar | MRK | ABBV | MTD |
|---|---|---|---|
| Climate Change | 68.4 | 74.0 | 83.4 |
| Employee Relations | 59.5 | 56.1 | 44.1 |
| Environment | 69.2 | 71.1 | 69.2 |
| Stakeholders & Society | 68.4 | 77.8 | 77.4 |
| Human Rights | 72.8 | 60.2 | 54.7 |
| Governance | 47.8 | 59.5 | 61.5 |
| Performance Rating | 73.9 | 63.6 | 57.8 |